Intrinsic Value of S&P & Nasdaq Contact Us

Leap Therapeutics, Inc. LPTX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
68/100
3/6 Pass
SharesGrow Intrinsic Value
$1.98
+157.3%
Analyst Price Target
$5.50
+614.7%

Stock Statistics — LPTX

Leap Therapeutics, Inc. (LPTX) has a market capitalization of $31.86M and trades at $0.77. The 52-week range is 0.2223-3.58.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 10.6, Earnings Per Share (EPS) of $0.07.

The stock has a beta of 0.09, operates in the Healthcare sector.

Trading Data
Current Price$0.77
52-Week Range0.2223-3.58
Volume848.47K
Avg Volume (30D)26.09M
Market Cap$31.86M
Beta (1Y)0.09
Company
IPO Date2017-01-25
Employees52
CEODouglas E. Onsi
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS52187K2006
CUSIP52187K101
Income (Latest Year)
EBITDA$-36.54M
Operating Income$-36.54M
Net Income$4.82M
EPS$0.07
EPS Diluted$0.07
Shares Outstanding$66.14M
Balance Sheet (Latest Year)
Total Assets$163.18M
Current Assets$162.08M
Cash & ST Investments$14.04M
Total Liabilities$9.68M
Total Debt$38K
Net Debt$-14M
Total Equity$153.51M
Debt / Equity0.00
Valuation Ratios
P/E Ratio10.6
P/B Ratio0.21
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message